UBS O'Connor’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

UBS O'Connor’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-705,024	Closed	-$6.97M	–	832
2022 Q3	$6.97M	Sell	705,024 -70,780	-9%	-$697K	0.08%	158
2022 Q2	$7.61M	Buy	+775,804	New	+$7.61M	0.08%	147
2022 Q1	–	Sell	-513,762	Closed	-$5.01M	–	697
2021 Q4	$5.01M	Buy	513,762 +13,780	+3%	+$135K	0.05%	266
2021 Q3	$4.86M	Hold	499,982	–	–	0.04%	318
2021 Q2	$4.84M	Hold	499,982	–	–	0.04%	280
2021 Q1	$4.81M	Buy	+499,982	New	+$4.88M	0.07%	276

UBS O'Connor's SSAA Position: Q4 2022 in Review

UBS O'Connor sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 705,024 shares — an estimated $6.97M sold.

UBS O'Connor first reported a position in SSAA in Q1 2021 and held it in 6 quarters. The position peaked at $7.61M in Q2 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

UBS O'Connor reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 705,024 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $6.97M.
UBS O'Connor first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q1 2021 and held it in 6 quarters.
UBS O'Connor's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $7.61M in Q2 2022.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.